InteRNA Technologies

InteRNA is a Dutch biotechnology company specializing in the development of RNA therapies for cancer treatment. Utilizing its leading microRNA (miRNA) discovery and functional validation platform, InteRNA is developing a series of proprietary preclinical miRNA candidates that target key processes in cancer initiation and progression. Enabled by third-generation drug delivery formulations, these miRNA compounds can mount a coordinated anti-cancer attack by simultaneously engaging multiple signaling targets.